Tinnitus Clinical Trial
Official title:
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Verified date | April 2019 |
Source | University of Minnesota - Clinical and Translational Science Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to investigate different stimulation parameters for a new noninvasive approach for modulating the brain that could potentially be beneficial for decreasing tinnitus perception. The new approach is called Multimodal Synchronization Therapy (mSync). mSync uses a combination of acoustic stimulation played through headphones and low levels of electrical current delivered via electrodes placed on the surface of different body regions. The timing interval between the acoustic and body stimulation is varied in order to cause different types of changes in the brain. In addition to acoustic and body stimulation, noninvasive cortical stimulation will also be presented as part of mSync to attempt to further modulate or decrease the tinnitus percept. Cortical stimulation will be performed by placing a magnetic coil over a spot on the head and sending a brief magnetic pulse that can travel through the skin and bone to create electrical current inside the head. For this study, different body locations as well as specific timing intervals among acoustic, body, and cortical stimulation will be investigated to identify appropriate parameters that can modulate and potentially decrease tinnitus perception. Different mSync parameters will be investigated across multiple testing sessions (up to 16 weekly sessions) and the tinnitus percept will be closely monitored throughout the study.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 13, 2017 |
Est. primary completion date | September 13, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Have subjective, non-pulsatile, and bothersome tinnitus - Will not start any new tinnitus treatment during the study - Ability to give informed consent and understand study objectives in English - Willing and able to understand and comply with all study-related procedures Exclusion Criteria: - Substantial hearing loss or hyperacusis that may interfere with the study - Medical history of other ear or brain disorders, history of seizures, or currently using any medication or treatments that can cause or increase the chances of seizures - Any implanted medical or metal device, such as a pacemaker, aneurysm clip, or cochlear implant - Pregnant or currently breast-feeding (we need to give all female subjects a pregnancy test because pregnant females and unborn children need extra protection for their safety) - Any handicap that prevents the subject from reliably performing the tests |
Country | Name | City | State |
---|---|---|---|
United States | Nils Hasselmo Hall, 6-105 | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota - Clinical and Translational Science Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Tinnitus Functional Index Questionnaire Score | A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. | Change from baseline score at 1 week after testing paradigm | |
Primary | Change in Minimal Masking Level | A narrowband noise (from 2-12 kHz) is presented to the tinnitus ear and the minimum sound level (in decibel sound pressure level, decibel SPL) is determined that completely masks the tinnitus percept. | Change in baseline level at an expected average of 1 minute and 1.5 hours after testing paradigm | |
Secondary | Change in Tinnitus Handicap Inventory Questionnaire Score | A series of questions to assess the quality and bothering nature of the tinnitus, which is then quantified into a single score. | Change from baseline score at 1 week after testing paradigm | |
Secondary | Change in Tinnitus Rating (0-10, 10 being worst) | The subject rates the disturbance or bothering nature of the tinnitus. | Change in baseline rating at an expected average of 4 minutes and 1.5 hours after testing paradigm | |
Secondary | Change in Tinnitus Subjective Description | The subject describes the quality, characteristics and bothering nature of the tinnitus. | Change in baseline description at an expected average of 5 minutes and 1.5 hours after testing paradigm | |
Secondary | Change in Tinnitus Matching (pitch and loudness) | The subject adjusts the loudness and pitch (i.e., frequency) of a sound played to an ear to that of the tinnitus percept. | Change in baseline pitch and loudness at an expected average of 1.5 hours after testing paradigm | |
Secondary | Daily Tinnitus Journal Entries | The subject describes the quality, characteristics and bothering nature of the tinnitus on a daily basis. The subject can also include any unusual or interesting events relating to the tinnitus that he/she feels would be relevant for the study. | 0, 1, 2, 3, 4, 5, 6, 7 days post-testing paradigm |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Recruiting |
NCT04987502 -
Virtual Reality and Subjective Tinnitus
|
N/A | |
Recruiting |
NCT04404439 -
Treatment of Tinnitus With Migraine Medications
|
Phase 4 | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT03552302 -
Effects of Yoga Exercise on Participates With Tinnitus
|
||
Enrolling by invitation |
NCT02617953 -
Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
|
N/A | |
Withdrawn |
NCT01663467 -
Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
|
N/A | |
Completed |
NCT02974543 -
Somatosensory Stimulation to Alleviate Tinnitus
|
N/A | |
Completed |
NCT02269839 -
A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus
|
N/A | |
Completed |
NCT01929837 -
Tinnitus rTMS 2013
|
N/A | |
Completed |
NCT01927991 -
Internet-based Self-help for Tinnitus: The Role of Support
|
N/A | |
Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
Completed |
NCT01480193 -
New Therapy for Patients With Severe Tinnitus
|
N/A | |
Terminated |
NCT01412918 -
Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression
|
N/A | |
Completed |
NCT00748475 -
Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus
|
N/A | |
Completed |
NCT00371436 -
Progressive Intervention Program for Tinnitus Management
|
N/A | |
Completed |
NCT00733044 -
Cost-effectiveness of Multidisciplinary Management of Tinnitus
|
N/A | |
Active, not recruiting |
NCT05518682 -
Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus
|
N/A | |
Recruiting |
NCT05212298 -
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 |